Olympus America

Press Center

New Olympus Carbamazepine, Gentamicin Plus, Procainamide, Barbiturate, Ethanol, and Methadone Reagents

Melville, NY - The Diagnostic Systems Group of Olympus America Inc. has introduced new Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DAT) reagents. In ready-to-use liquid formulations, the new TDMs (Carbamazepine, Gentamicin Plus, and Procainamide) and DATs (Barbiturate, Ethanol, and Methadone) feature 90-day to 60-day on-board stability with 14-day calibration stability on Olympus' full line of automated chemistry-immuno analyzers, including the AU400TM, AU600TM, AU640TM, and AU2700TM systems.

The new Olympus TDM and DAT reagents are bar coded, providing greater operator convenience by enabling automated on-board reagent management.

The full line of Emit® 2000 TDM reagents and Emit® II Plus DAT reagents are expected to be available in Olympus bar-coded packaging later this year. Olympus will also continue to distribute the full line of Emit® 1.0 TDM reagents in existing Syva packaging. Olympus TDM and DAT reagents are manufactured at a subsidiary of Dade Behring Inc., Syva Company, an ISO 9001-registered facility. Emit® is a registered trademark of Dade Behring Inc.

The Diagnostic Systems Group, a business unit of Olympus America Inc., provides innovative solutions that meet the high productivity demands of today's hospitals, integrated health care delivery networks, blood banks, reference labs, and pharmaceutical labs. More than 1 billion clinical chemistry tests are performed on Olympus analyzers in the U.S. annually.

For additional information, please contact Olympus America Inc., Two Corporate Center Drive, Melville, NY 11747-3157. Telephone: (631) 844-5000, fax: (631) 844-5692.

Note to the editor: Olympus America Inc. distributes a wide range of products that leverage its core expertise in optics and digital information technology for the consumer, scientific, health care, and commercial markets. These products include film and digital cameras, micro cassettes and digital voice recorders, binoculars, film scanners, personal photo printers, medical endoscopes, biological and metallurgical microscopes and measuring instruments, clinical diagnostic analyzers, and other high-technology products. Olympus America Inc. is responsible for sales, marketing, and distribution in the U.S., Canada, Mexico, the Caribbean, and Central and South America. Located in Melville, NY, Olympus America Inc. is a subsidiary of Olympus Optical Co., Ltd. with worldwide revenues of $4.2 billion for the fiscal year ending March 2001.